Marinomed Biotech AG | WebDisclosure

Basculer en Français

9479	Companies
185504	Keywords
117879	Articles
99354	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 09/15/2024 at 17:49, 1 year 2 months ago

EQS-Adhoc: Marinomed Biotech AG sets price range for potential 10% capital increase and potential second capital increase, in each case excluding statutory subscription rights
Marinomed Biotech AG sets price range for potential 10% capital increase and second capital increase, excluding statutory subscription rights

Capital Increase Marinomed Biotech AG Price Range Authorized Capital 2024 Restructuring Proceedings
BRIEF

published on 09/11/2024 at 07:50, 1 year 2 months ago

Marinomed Biotech AG: First Carragelose Products Receive New Medical Device Regulation (MDR) Certification

Regulatory Compliance Medical Devices Carragelose MDR Certification Marinomed
BRIEF

published on 09/11/2024 at 07:50, 1 year 2 months ago

Marinomed Biotech AG : les premiers produits à base de carraghénane reçoivent la nouvelle certification du Règlement sur les dispositifs médicaux (MDR)

Dispositifs Médicaux Conformité Réglementaire Certification MDR Marinomé Carraghénose
PRESS RELEASE

published on 09/11/2024 at 07:45, 1 year 2 months ago

Marinomed Biotech AG: First Carragelose products receive new Medical Device Regulation (MDR) certification
Marinomed Biotech AG's first Carragelose products receive new Medical Device Regulation (MDR) certification, enhancing safety and value for the portfolio

Regulatory Compliance Medical Devices Marinomed Biotech AG MDR Certification Carragelose Products
BRIEF

published on 09/02/2024 at 17:51, 1 year 3 months ago

Marinomed Biotech AG Evaluates 10% Capital Increase

Investors Shares Capital Increase Restructuring Marinomed
BRIEF

published on 09/02/2024 at 17:51, 1 year 3 months ago

Marinomed Biotech AG évalue une augmentation de capital de 10 %

Actions Augmentation De Capital Investisseurs Restructuration Marinomé
PRESS RELEASE

published on 09/02/2024 at 17:46, 1 year 3 months ago

EQS-Adhoc: Marinomed Biotech AG evaluates possible 10% capital increase with exclusion of statutory subscription rights
Marinomed Biotech AG evaluates a possible 10% capital increase excluding statutory subscription rights to finance ongoing costs in restructuring proceedings. Management Board to discuss with selected investors for potential transaction

Capital Increase Management Board Marinomed Biotech AG Restructuring Proceedings Statutory Subscription Rights
BRIEF

published on 08/20/2024 at 18:05, 1 year 3 months ago

Marinomed Biotech AG Reports Preliminary Financial Figures for H1 2024

Financial Results Product Development Restructuring Proceedings Q2 Revenue Growth New Partnerships
BRIEF

published on 08/20/2024 at 18:05, 1 year 3 months ago

Marinomed Biotech AG publie ses résultats financiers préliminaires pour le premier semestre 2024

Résultats Financiers Développement De Produits Croissance Du Chiffre D'affaires Au Deuxième Trimestre Procédure De Restructuration Nouveaux Partenariats
PRESS RELEASE

published on 08/20/2024 at 18:00, 1 year 3 months ago

Marinomed Biotech AG reports preliminary financial figures for the first half of 2024
Marinomed Biotech AG reports preliminary financial figures for the first half of 2024, including a decline in revenues compared to 2023. The company aims to stabilize through restructuring and new partnerships

Restructuring Preliminary Results Financial Figures Partnerships Marinomed Biotech AG

Accesswire

Published on 12/05/2025 at 17:15, 13 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 28 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 1 hour 28 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots
Published on 12/05/2025 at 15:45, 1 hour 43 minutes ago

Critical Elements announce la clôture d'un placement privé de 7,0 $ million ca par voie de prise ferme
Published on 12/05/2025 at 15:45, 1 hour 43 minutes ago

Critical Elements Announces Closing of C$7.0 Million Bought Deal Life Private Placement

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 17:00, 27 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 1 hour 2 minutes ago

4YFN26 Awards: Meet the Top 20 startups building the future
Published on 12/05/2025 at 16:10, 1 hour 18 minutes ago

Reorganization of the Eckert & Ziegler Executive Board
Published on 12/05/2025 at 16:00, 1 hour 27 minutes ago

EQS-Adhoc: TIN INN Holding AG implements financing strategy
Published on 12/05/2025 at 16:00, 1 hour 27 minutes ago

EQS-Adhoc: Amundi Physical Metals plc: Release of the Half-Year Financial Report as of September 30, 2025

Les Echos

Published on 12/05/2025 at 17:18, 10 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 10 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 2 hours 17 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 2 hours 17 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 3 hours 29 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE